ArticleNucleosides, nucleotides & nucleic acids2008

Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.

Andrea V Leisewitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.